1-磷酸鞘氨醇通过保护内皮线粒体完整性减少失血性休克与复苏诱导的微血管渗漏
本研究在大鼠失血性休克与复苏(HSR)在体模型中,用活体显微镜评估微血管渗漏、内皮糖萼完整性和线粒体功能,并用共聚焦显微镜评估肠系膜微循环连接完整性;同时用培养的大鼠肠微血管内皮细胞单层,测试S1P对线粒体复合物III抑制所致糖萼脱落和内皮屏障功能障碍的保护作用。结果显示,在体S1P可减轻HSR诱导的高通透性、保护黏附连接蛋白表达、防止糖萼降解,并保护线粒体膜去极化;体外S1P通过线粒体复合物III保护线粒体功能障碍所致的内皮屏障功能障碍和糖萼降解。作者认为S1P保护HSR诱导的内皮细胞线粒体功能障碍,进而改善HSR后内皮糖萼结构并维持连接完整性,防止过度微血管通透性。
要点
- 在大鼠在体HSR模型中,S1P治疗可减轻HSR诱导的微血管高通透性。
- S1P在HSR期间治疗可保护黏附连接蛋白表达并防止内皮糖萼降解。
- S1P在HSR期间治疗可保护线粒体膜去极化。
- 体外培养大鼠肠微血管内皮细胞单层中,S1P通过线粒体复合物III保护线粒体功能障碍所致的内皮屏障功能障碍和糖萼降解。
适用人群与场景
- 研究使用清醒大鼠在体HSR模型,以及培养的大鼠肠微血管内皮细胞单层;原文未报告临床患者纳入或排除人群。
研究设计与关键结果
- 研究类型为在体大鼠HSR模型结合体外培养大鼠肠微血管内皮细胞单层的实验研究;原文未报告样本量。
- 在体实验中,S1P减轻HSR诱导的微血管高通透性、保护黏附连接蛋白表达、防止糖萼降解并保护线粒体膜去极化。
- 体外实验中,S1P通过线粒体复合物III保护线粒体功能障碍所致的内皮屏障功能障碍和糖萼降解。
证据类型、等级与局限
- 证据类型:在体大鼠HSR模型与体外细胞实验(动物实验与体外研究);原文未报告证据等级或推荐强度。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出临床推荐;作者认为S1P通过保护HSR诱导的内皮细胞线粒体功能障碍,进而改善内皮糖萼结构和连接完整性,防止过度微血管通透性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Excessive microvascular permeability is a serious complication following hemorrhagic shock and resuscitation (HSR). S1P has been shown to ameliorate microvascular leakage in a model of combined alcohol intoxication and HSR. In the current study, we tested the hypothesis that S1P reduces HSR-induced microvascular leakage by preserving endothelial cell junctional structure and the endothelial glycocalyx through the protection of mitochondrial function. We used an established in vivo rat model of conscious HSR and assessed microvascular leakage, endothelial glycocalyx integrity, and mitochondrial function by intravital microscopy. Junctional integrity in the mesenteric microcirculation was assessed by confocal microscopy. Cultured rat intestinal microvascular endothelial cells monolayers were used to test the ability of S1P to protect against glycocalyx shedding and endothelial barrier dysfunction caused by direct disruption of mitochondrial integrity due to inhibition of mitochondrial complex III. The results show that in vivo, S1P protects against HSR-induced hyperpermeability, preserves the expression of adherens junctional proteins, and protects against glycocalyx degradation. S1P treatment during HSR also protects against mitochondrial membrane depolarization. S1P also protects against mitochondrial dysfunction-induced endothelial barrier dysfunction and glycocalyx degradation by acting through mitochondrial complex III. Taken together, our data indicate that S1P protects against HSR-induced mitochondrial dysfunction in endothelial cells, which in turn improves the structure of the endothelial glycocalyx after HSR and allows for better junctional integrity to the prevention of excess microvascular permeability.
参考来源
- Alves NG, Trujillo AN, Breslin JW, et al. Sphingosine-1-Phosphate Reduces Hemorrhagic Shock and Resuscitation-Induced Microvascular Leakage by Protecting Endothelial Mitochondrial Integrity. Shock. 2019. PMID: 30339634. doi:10.1097/SHK.0000000000001280
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。